S
Shanghai Universal Biotech Co Ltd
SZSE:301166
Shanghai Universal Biotech Co Ltd
SZSE:301166
Price:
30.52
CNY
-1.29%
Market Closed
Market Cap:
¥2.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shanghai Universal Biotech Co Ltd
SZSE:301166
|
CN |
|
N
|
NK Lukoil PAO
LSE:LKOH
|
RU |
|
Virscend Education Company Ltd
HKEX:1565
|
CN |
|
H
|
Hubei Jiuzhiyang Infrared System Co Ltd
SZSE:300516
|
CN |
|
CMOC Group Ltd
SSE:603993
|
CN |
|
C
|
Cowell e Holdings Inc
HKEX:1415
|
CN |
|
K
|
Kuchai Development Bhd
KLSE:KUCHAI
|
MY |
|
G
|
Gilat Telecom Global Ltd
TASE:GLTL
|
IL |
|
Z
|
Zhejiang Wanfeng Auto Wheel Co Ltd
SZSE:002085
|
CN |
|
Zhejiang Mustang Battery Co Ltd
SSE:605378
|
CN |
|
QVC Group Inc
OTC:QVCGB
|
US |
Income Statement
Earnings Waterfall
Shanghai Universal Biotech Co Ltd
Shanghai Universal Biotech Co Ltd
Income Statement
Shanghai Universal Biotech Co Ltd
Shanghai Universal Biotech Co Ltd
Currency: CNY
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
0
|
2
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Revenue |
1 357
N/A
|
1 072
-21%
|
1 110
+3%
|
1 115
+1%
|
1 104
-1%
|
1 178
+7%
|
1 195
+1%
|
1 228
+3%
|
1 267
+3%
|
1 220
-4%
|
1 226
+1%
|
1 223
0%
|
1 204
-2%
|
1 167
-3%
|
1 118
-4%
|
1 062
-5%
|
1 070
+1%
|
1 066
0%
|
|
| Gross Profit | |||||||||||||||||||
| Cost of Revenue |
(1 052)
|
(827)
|
(853)
|
(865)
|
(854)
|
(917)
|
(931)
|
(958)
|
(991)
|
(968)
|
(996)
|
(994)
|
(988)
|
(958)
|
(916)
|
(879)
|
(887)
|
(879)
|
|
| Gross Profit |
306
N/A
|
246
-20%
|
257
+5%
|
250
-3%
|
250
0%
|
261
+5%
|
265
+1%
|
270
+2%
|
277
+2%
|
251
-9%
|
230
-8%
|
229
0%
|
216
-6%
|
209
-3%
|
201
-4%
|
184
-9%
|
183
0%
|
187
+2%
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(151)
|
(116)
|
(123)
|
(124)
|
(145)
|
(158)
|
(173)
|
(189)
|
(201)
|
(217)
|
(229)
|
(246)
|
(239)
|
(237)
|
(234)
|
(226)
|
(236)
|
(242)
|
|
| Selling, General & Administrative |
(147)
|
(108)
|
(111)
|
(115)
|
(128)
|
(140)
|
(142)
|
(154)
|
(160)
|
(168)
|
(173)
|
(181)
|
(176)
|
(171)
|
(167)
|
(168)
|
(175)
|
(183)
|
|
| Research & Development |
(15)
|
(13)
|
(15)
|
(18)
|
(22)
|
(28)
|
(32)
|
(43)
|
(49)
|
(51)
|
(53)
|
(60)
|
(63)
|
(66)
|
(58)
|
(63)
|
(62)
|
(66)
|
|
| Depreciation & Amortization |
0
|
0
|
(7)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
11
|
5
|
10
|
10
|
5
|
10
|
6
|
8
|
8
|
2
|
8
|
(5)
|
1
|
0
|
6
|
5
|
1
|
7
|
|
| Operating Income |
155
N/A
|
130
-16%
|
134
+4%
|
126
-6%
|
104
-17%
|
104
-1%
|
91
-12%
|
81
-11%
|
76
-7%
|
35
-54%
|
1
-98%
|
(16)
N/A
|
(23)
-42%
|
(28)
-20%
|
(33)
-17%
|
(42)
-30%
|
(54)
-26%
|
(55)
-2%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
5
|
4
|
4
|
10
|
19
|
27
|
37
|
40
|
41
|
40
|
35
|
34
|
30
|
31
|
35
|
30
|
28
|
25
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
160
N/A
|
134
-17%
|
138
+3%
|
136
-1%
|
123
-10%
|
131
+6%
|
129
-2%
|
121
-6%
|
116
-4%
|
74
-36%
|
35
-52%
|
18
-51%
|
7
-59%
|
2
-79%
|
1
-47%
|
(14)
N/A
|
(27)
-96%
|
(30)
-10%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
(33)
|
(28)
|
(29)
|
(27)
|
(24)
|
(22)
|
(22)
|
(18)
|
(16)
|
(7)
|
5
|
10
|
14
|
13
|
9
|
13
|
9
|
11
|
|
| Income from Continuing Operations |
128
|
106
|
109
|
109
|
98
|
108
|
106
|
103
|
100
|
68
|
40
|
28
|
21
|
14
|
10
|
(1)
|
(18)
|
(19)
|
|
| Net Income (Common) |
128
N/A
|
106
-17%
|
109
+3%
|
109
+0%
|
98
-10%
|
108
+10%
|
106
-2%
|
103
-4%
|
100
-2%
|
68
-32%
|
40
-41%
|
28
-32%
|
21
-24%
|
14
-32%
|
10
-28%
|
(1)
N/A
|
(18)
-1 352%
|
(19)
-4%
|
|
| EPS (Diluted) |
1.17
N/A
|
1.23
+5%
|
1.25
+2%
|
1.25
N/A
|
1.14
-9%
|
1.25
+10%
|
1.23
-2%
|
1.18
-4%
|
1.16
-2%
|
0.78
-33%
|
0.47
-40%
|
0.32
-32%
|
0.24
-25%
|
0.16
-33%
|
0.12
-25%
|
-0.01
N/A
|
-0.21
-2 000%
|
-0.22
-5%
|
|
Switch to:
Switch to:
See Also
Discover More
